Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Comparison of low-dose cytosine arabinoside and aclarubicin in combination with granulocyte colony-stimulating factor to intermediate-dose cytosine arabinoside and mitoxantrone with or without etoposide in the treatment of relapsed acute myeloid leukemia].
Saito K, Furusawa S, Yamada K, Waga K, Aoyagi A, Koike T, Arimura H, Noguchi M, Yamato H, Sakuma H, et al. Saito K, et al. Among authors: aoyagi a. Rinsho Ketsueki. 1995 Mar;36(3):165-74. Rinsho Ketsueki. 1995. PMID: 7540220 Clinical Trial. Japanese.
Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformation.
Saito K, Nakamura Y, Aoyagi M, Waga K, Yamamoto K, Aoyagi A, Inoue F, Nakamura Y, Arai Y, Tadokoro J, Handa T, Tsurumi S, Arai H, Kawagoe Y, Gunnji H, Kitsukawa Y, Takahashi W, Furusawa S. Saito K, et al. Among authors: aoyagi m, aoyagi a. Int J Hematol. 2000 Apr;71(3):238-44. Int J Hematol. 2000. PMID: 10846828
[FAB classification, response to therapy, and survival in adult patients with acute leukemia].
Moriyama Y, Aoki S, Urushiyama M, Ohnishi M, Hirosawa H, Koyama S, Hanano M, Fuse I, Takai K, Nagayama R, Fujiwara M, Kishi K, Takahashi M, Koike T, Sakai C, Kashimura M, Takahashi H, Miura R, Aoyagi A, Sanada M, Hattori A, Shibata A, Shinada S. Moriyama Y, et al. Among authors: aoyagi a. Rinsho Ketsueki. 1982 Nov;23(11):1706-12. Rinsho Ketsueki. 1982. PMID: 6962910 Japanese. No abstract available.
[Therapeutic results of DCMP therapy (2M-80) in acute non-lymphocytic leukemia--the relationship between the residual leukemic cells and duration of remission].
Moriyama Y, Urushiyama M, Ohnishi M, Koyama S, Hirosawa H, Hanano M, Fuse I, Takai K, Nagayama R, Fujiwara M, Kishi K, Takahashi M, Koike T, Sakai C, Kashimura M, Miura R, Aoyagi A, Sanada M, Hattori A, Shibata A, Shinada S. Moriyama Y, et al. Among authors: aoyagi a. Gan To Kagaku Ryoho. 1982 Sep;9(9):1549-54. Gan To Kagaku Ryoho. 1982. PMID: 6892201 Japanese.
78 results